editor, reviewer
1,499
edits
Changes
no edit summary
'''General considerations'''<ref>
# The goal of this switching table is to offer a guide for physician and pharmacist in switching antipsychotics. The table should be clear, easy to use and contain the most important information. Therefore, the table only contains the most common or special antipsychotics. There is also a group ‘rest AP’, containing antipsychotics with the same switching advice.</ref>
# It should be noted that the table only contains a general advice.
# Because of the risk of acute withdrawal symptoms (e.g. cholinergic rebound) and the risk of relapse, all antipsychotics are gradually tapered.
# Warnings and advice are limited to the switch only. Specific drug properties can be found via the links on the right.
# Cytochrome P450 drug interactions between different antipsychotics are checked with the Flockart interaction table. No inductors or inhibitors were found.
# Nearly all antipsychotics increase the risk of QT time prolongation with or without Torsade de Pointes (TDP). Under the heading ‘more information’ there is a recommendation, advising ECG monitoring. The SPC of sertindole contains the warning ECG monitoring required. No distinction has been made between drugs with and without TDP.</ref>
[[category:Switchtable]]
